Theoretical and experimental evidence on the use of glycosaminoglycans in BCG-mediated immunotherapy of superficial bladder cancer

Semin Thromb Hemost. 1994;20(3):301-9. doi: 10.1055/s-2007-1001917.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adsorption
  • Animals
  • BCG Vaccine / therapeutic use*
  • Combined Modality Therapy
  • Eukaryotic Cells / microbiology
  • Glycosaminoglycans / metabolism
  • Glycosaminoglycans / therapeutic use*
  • Humans
  • Mycobacterium bovis / immunology
  • Proteoglycans / metabolism
  • Urinary Bladder Neoplasms / metabolism
  • Urinary Bladder Neoplasms / therapy*

Substances

  • BCG Vaccine
  • Glycosaminoglycans
  • Proteoglycans